USD 0.75
(-9.64%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 | 590.33 Thousand USD | -43.82% |
2023 | 1.05 Million USD | -8.93% |
2022 | 1.15 Million USD | -7.87% |
2021 | 1.25 Million USD | -1.09% |
2020 | 1.26 Million USD | 280.34% |
2019 | 332.89 Thousand USD | -94.7% |
2018 | 6.28 Million USD | -55.52% |
2017 | 14.12 Million USD | -28.38% |
2016 | 19.71 Million USD | 100.2% |
2015 | 9.84 Million USD | 0.0% |
2014 | - USD | -100.0% |
2013 | 19.9 Thousand USD | -52.81% |
2012 | 42.18 Thousand USD | -45.29% |
2011 | 77.1 Thousand USD | 127.1% |
2010 | 33.95 Thousand USD | -72.08% |
2009 | 121.62 Thousand USD | -68.39% |
2008 | 384.75 Thousand USD | -21.79% |
2007 | 491.96 Thousand USD | 55.61% |
2006 | 316.14 Thousand USD | 946.75% |
2005 | 30.2 Thousand USD | -52.58% |
2004 | 63.69 Thousand USD | -75.91% |
2003 | 264.44 Thousand USD | 0.0% |
2002 | - USD | -100.0% |
2001 | 27.77 Thousand USD | 0.0% |
2000 | - USD | -100.0% |
1999 | 2 Million USD | 122.22% |
1998 | 900 Thousand USD | -50.0% |
1997 | 1.8 Million USD | -44.71% |
1996 | 3.25 Million USD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q3 | 706.64 Thousand USD | -13.97% |
2024 Q2 | 821.37 Thousand USD | -12.09% |
2024 Q1 | 934.32 Thousand USD | -11.08% |
2024 Q4 | 426.55 Thousand USD | -16.46% |
2023 Q2 | 919.42 Thousand USD | -11.38% |
2023 Q3 | 799.79 Thousand USD | -13.01% |
2023 FY | 1.05 Million USD | -8.93% |
2023 Q1 | 1.03 Million USD | -10.09% |
2023 Q4 | 1.05 Million USD | 31.38% |
2022 Q1 | 1.16 Million USD | -7.16% |
2022 Q2 | 1.37 Million USD | 18.54% |
2022 Q3 | 1.26 Million USD | -8.09% |
2022 FY | 1.15 Million USD | -7.87% |
2022 Q4 | 1.15 Million USD | -8.92% |
2021 Q4 | 1.25 Million USD | -6.07% |
2021 Q1 | 1.19 Million USD | -5.69% |
2021 Q2 | 1.12 Million USD | -6.12% |
2021 FY | 1.25 Million USD | -1.09% |
2021 Q3 | 1.33 Million USD | 18.94% |
2020 Q4 | 1.26 Million USD | 13871.88% |
2020 Q1 | - USD | -100.0% |
2020 FY | 1.26 Million USD | 280.34% |
2020 Q3 | 9062.00 USD | -32.81% |
2020 Q2 | 13.48 Thousand USD | 0.0% |
2019 Q4 | 332.89 Thousand USD | -74.95% |
2019 Q3 | 1.32 Million USD | -42.74% |
2019 Q2 | 2.32 Million USD | -46.09% |
2019 Q1 | 4.3 Million USD | -31.46% |
2019 FY | 332.89 Thousand USD | -94.7% |
2018 FY | 6.28 Million USD | -55.52% |
2018 Q2 | 10.21 Million USD | -16.1% |
2018 Q1 | 12.16 Million USD | -13.82% |
2018 Q4 | 6.28 Million USD | -23.86% |
2018 Q3 | 8.25 Million USD | -19.2% |
2017 Q2 | 17.66 Million USD | -5.0% |
2017 FY | 14.12 Million USD | -28.38% |
2017 Q3 | 16.06 Million USD | -9.07% |
2017 Q1 | 18.59 Million USD | -5.68% |
2017 Q4 | 14.12 Million USD | -12.1% |
2016 Q4 | 19.71 Million USD | 0.22% |
2016 FY | 19.71 Million USD | 100.2% |
2016 Q1 | 19.58 Million USD | 98.88% |
2016 Q2 | 19.63 Million USD | 0.22% |
2016 Q3 | 19.67 Million USD | 0.22% |
2015 Q2 | 9.81 Million USD | -0.17% |
2015 FY | 9.84 Million USD | 0.0% |
2015 Q1 | 9.83 Million USD | 0.0% |
2015 Q3 | 9.83 Million USD | 0.17% |
2015 Q4 | 9.84 Million USD | 0.17% |
2014 Q3 | 2048.00 USD | -74.76% |
2014 FY | - USD | -100.0% |
2014 Q2 | 8115.00 USD | -42.32% |
2014 Q1 | 14.06 Thousand USD | -29.34% |
2014 Q4 | - USD | -100.0% |
2013 Q3 | 25.63 Thousand USD | -17.98% |
2013 Q4 | 19.9 Thousand USD | -22.35% |
2013 FY | 19.9 Thousand USD | -52.81% |
2013 Q1 | 36.77 Thousand USD | -12.83% |
2013 Q2 | 31.26 Thousand USD | -15.0% |
2012 Q2 | 56.36 Thousand USD | -15.69% |
2012 Q3 | 47.49 Thousand USD | -15.74% |
2012 Q4 | 42.18 Thousand USD | -11.18% |
2012 FY | 42.18 Thousand USD | -45.29% |
2012 Q1 | 66.85 Thousand USD | -13.3% |
2011 Q3 | 19.39 Thousand USD | -20.43% |
2011 Q4 | 77.1 Thousand USD | 297.61% |
2011 FY | 77.1 Thousand USD | 127.1% |
2011 Q1 | 29.22 Thousand USD | -13.93% |
2011 Q2 | 24.37 Thousand USD | -16.61% |
2010 FY | 33.95 Thousand USD | -72.08% |
2010 Q4 | 33.95 Thousand USD | -11.95% |
2010 Q3 | 38.56 Thousand USD | -13.69% |
2010 Q2 | 44.67 Thousand USD | -39.93% |
2010 Q1 | 74.37 Thousand USD | -38.85% |
2009 Q3 | 180.37 Thousand USD | -26.58% |
2009 FY | 121.62 Thousand USD | -68.39% |
2009 Q4 | 121.62 Thousand USD | -32.57% |
2009 Q2 | 245.68 Thousand USD | -22.75% |
2009 Q1 | 318.01 Thousand USD | -17.35% |
2008 Q4 | 384.75 Thousand USD | -16.76% |
2008 Q1 | 601.12 Thousand USD | 22.19% |
2008 FY | 384.75 Thousand USD | -21.79% |
2008 Q2 | 544.95 Thousand USD | -9.34% |
2008 Q3 | 462.21 Thousand USD | -15.18% |
2007 Q1 | 404 Thousand USD | 27.79% |
2007 FY | 491.96 Thousand USD | 55.61% |
2007 Q3 | 550.08 Thousand USD | 14.45% |
2007 Q4 | 491.96 Thousand USD | -10.57% |
2007 Q2 | 480.62 Thousand USD | 18.97% |
2006 Q3 | 336.67 Thousand USD | -4.1% |
2006 Q4 | 316.14 Thousand USD | -6.1% |
2006 FY | 316.14 Thousand USD | 946.75% |
2006 Q2 | 351.06 Thousand USD | 1177.51% |
2006 Q1 | 27.48 Thousand USD | -9.02% |
2005 Q4 | 30.2 Thousand USD | -5.57% |
2005 Q3 | 31.98 Thousand USD | -7.57% |
2005 Q2 | 34.6 Thousand USD | -6.9% |
2005 Q1 | 37.16 Thousand USD | -41.65% |
2005 FY | 30.2 Thousand USD | -52.58% |
2004 FY | 63.69 Thousand USD | -75.91% |
2004 Q4 | 63.69 Thousand USD | -44.24% |
2004 Q3 | 114.23 Thousand USD | -27.32% |
2004 Q1 | 211.1 Thousand USD | -20.17% |
2004 Q2 | 157.17 Thousand USD | -25.54% |
2003 Q2 | 294.34 Thousand USD | -9.86% |
2003 Q1 | 326.52 Thousand USD | 0.0% |
2003 FY | 264.44 Thousand USD | 0.0% |
2003 Q3 | 259.47 Thousand USD | -11.84% |
2003 Q4 | 264.44 Thousand USD | 1.91% |
2002 Q2 | - USD | 0.0% |
2002 Q1 | - USD | -100.0% |
2002 Q3 | - USD | 0.0% |
2002 FY | - USD | -100.0% |
2002 Q4 | - USD | 0.0% |
2001 Q2 | - USD | 0.0% |
2001 Q4 | 27.77 Thousand USD | 0.0% |
2001 Q3 | - USD | 0.0% |
2001 FY | 27.77 Thousand USD | 0.0% |
2001 Q1 | - USD | 0.0% |
2000 Q1 | - USD | -100.0% |
2000 FY | - USD | -100.0% |
2000 Q2 | - USD | 0.0% |
2000 Q3 | - USD | 0.0% |
2000 Q4 | - USD | 0.0% |
1999 Q1 | 700 Thousand USD | -22.22% |
1999 FY | 2 Million USD | 122.22% |
1999 Q4 | 2 Million USD | 900.0% |
1999 Q3 | 200 Thousand USD | -50.0% |
1999 Q2 | 400 Thousand USD | -42.86% |
1998 Q3 | 1.2 Million USD | -7.69% |
1998 FY | 900 Thousand USD | -50.0% |
1998 Q1 | 1.7 Million USD | -10.53% |
1998 Q2 | 1.3 Million USD | -23.53% |
1998 Q4 | 900 Thousand USD | -25.0% |
1997 Q1 | 2.1 Million USD | -34.38% |
1997 Q2 | 2.1 Million USD | 0.0% |
1997 Q4 | 1.9 Million USD | -5.0% |
1997 Q3 | 2 Million USD | -4.76% |
1997 FY | 1.8 Million USD | -44.71% |
1996 FY | 3.25 Million USD | 0.0% |
1996 Q4 | 3.2 Million USD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
AIM ImmunoTech Inc. | 495 Thousand USD | -19.26% |
Ampio Pharmaceuticals, Inc. | 274 Thousand USD | -115.452% |
Armata Pharmaceuticals, Inc. | 120.37 Million USD | 99.51% |
Actinium Pharmaceuticals, Inc. | 2.11 Million USD | 72.062% |
Azitra, Inc. | 885.94 Thousand USD | 33.366% |
Can-Fite BioPharma Ltd. | 39.99 Thousand USD | -1375.882% |
Chromocell Therapeutics Corporation | 1.26 Million USD | 53.469% |
Calidi Biotherapeutics, Inc. | 7.23 Million USD | 91.842% |
CEL-SCI Corporation | 13.57 Million USD | 95.65% |
iBio, Inc. | 4.46 Million USD | 86.764% |
Lineage Cell Therapeutics, Inc. | 2.95 Million USD | 80.002% |
MAIA Biotechnology, Inc. | - USD | -Infinity% |
Matinas BioPharma Holdings, Inc. | 3.55 Million USD | 83.399% |
Navidea Biopharmaceuticals, Inc. | 2.43 Million USD | 75.749% |
NovaBay Pharmaceuticals, Inc. | 2.74 Million USD | 78.455% |
NanoViricides, Inc. | - USD | -Infinity% |
Oragenics, Inc. | 312.7 Thousand USD | -88.786% |
BiomX Inc. | 15.09 Million USD | 96.088% |
BiomX Inc. | 15.09 Million USD | 96.088% |
Protalix BioTherapeutics, Inc. | 26.28 Million USD | 97.754% |
Scorpius Holdings, Inc. | 14.04 Million USD | 95.796% |